Literature DB >> 22136912

ENPP1 K121Q polymorphism and type 2 diabetes mellitus in the Chinese population: a meta-analysis including 11,855 subjects.

Yan-yan Li1.   

Abstract

Ectoenzyme nucleotide pyrophosphate phosphodiesterase 1 (ENPP1) K121Q gene polymorphism has been suggested to be associated with the increased risk of developing type 2 diabetes mellitus (T2D), but relevant research results are still contradictory. To explore the relationship between ENPP1 K121Q gene polymorphism and T2D in the Chinese population, a meta-analysis was performed. Fourteen independent studies involving 11 855 subjects were retrieved from electronic databases. The pooled odds ratio (ORs) for the distribution of Q allele frequency of the ENPP1 K121Q gene and its corresponding 95% confidence interval (95% CI) were assessed using a random-effects model. Under an allelic model of inheritance, the distribution of Q allele frequency was 0.107 for the T2D group and 0.093 for the control group. The pooled OR for the distribution of Q allele frequency of ENPP1 K121Q gene was 1.29 (95% CI, 1.09-1.53; P(heterogeneity) = .006; I(2) = 55.6%). There was a significant association between ENPP1 K121Q gene polymorphism and T2D in the Chinese population (P = .003). Under a dominant model of inheritance, the KQ + QQ/KK value was 0.259 for the T2D group and 0.220 for the control group. The pooled OR for the KQ + QQ/KK value was 1.51 (95% CI, 1.20-1.91; P(heterogeneity) < .0001; I(2) = 71.8%). The association between ENPP1 K121Q gene polymorphism and T2D in the Chinese population followed a dominant model of inheritance (P = .0005). In the Chinese population, the ENPP1 K121Q gene polymorphism was implied to be involved with T2D susceptibility. People with the Q allele of the ENPP1 K121Q gene might be predisposed to T2D.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136912     DOI: 10.1016/j.metabol.2011.10.002

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  The association between the FABP2 Ala54Thr variant and the risk of type 2 diabetes mellitus: a meta-analysis based on 11 case-control studies.

Authors:  Peng Liu; Dan Yu; Xiaoping Jin; Cai Li; Feng Zhu; Zhou Zheng; Chenlin Lv; Xinwei He
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 2.  SIRT1-SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms.

Authors:  Wenxiu Qi; Cheng Hu; Daqing Zhao; Xiangyan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-13       Impact factor: 6.055

3.  Contribution of ENPP1, TCF7L2, and FTO polymorphisms to type 2 diabetes in mixed ancestry ethnic population of South Africa.

Authors:  Yandiswa Y Yako; Jabulisile H Madubedube; Andre P Kengne; Rajiv T Erasmus; Tahir S Pillay; Tandi E Matsha
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

4.  CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: a meta-analysis of 62,567 subjects.

Authors:  Yan-yan Li; Lian-sheng Wang; Xin-zheng Lu; Zhi-jian Yang; Xiang-ming Wang; Chuan-wei Zhou; Jian Xu; Yun Qian; Ai-ling Chen
Journal:  Sci Rep       Date:  2013-11-04       Impact factor: 4.379

Review 5.  Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: a systematic review and meta-analysis.

Authors:  Denise Alves Sortica; Marjorie Piucco Buffon; Bianca Marmontel Souza; Bruna Bellicanta Nicoletto; Andressa Santer; Tais Silveira Assmann; Daisy Crispim; Luis Henrique Canani
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

6.  Association of the ENPP1/ENTPD1 Polymorphisms in Hemodialysis Patients.

Authors:  Xi Zhang; Ziming Wan; Si Cheng; Hua Gan
Journal:  Int J Gen Med       Date:  2021-10-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.